News
Individuals who received either the AS01 shingles or RSV vaccine had a significantly lower risk of developing dementia.
Compared with flu vaccine recipients, those given the RSV or shingles vaccine had 18% to 37% lower odds of receiving a ...
AS01-adjuvanted RSV and shingles vaccines were tied to a lower dementia risk in older adults. Compared with flu vaccine recipients, those who had the AS01 RSV shot had 29% more dementia-free time ...
It is not clear how AS01 might help lower the risk of dementia, but Oxford University said lab studies show that the adjuvant stimulates cells of the immune system that could help protect the ...
The WHO has given a green light to widespread use of GlaxoSmithKline's malaria vaccine in Africa, in what could be a major turning point in the fight against the disease. The RTS,S/AS01 vaccine ...
Researchers found that older adults who received AS01-adjuvanted shingles or RSV vaccines had a significantly lower risk of developing dementia within 18 months compared to flu vaccine recipients.
A new study from the University of Oxford has revealed a surprising benefit of the respiratory syncytial virus (RSV) vaccine: ...
Incredible value: Save up to $700 or 53% off during Amazon Prime Day, the best time to upgrade your tech. Something for ...
4h
News-Medical.Net on MSNResearch reveals alarming rates of abuse in home-based dementia careIn a recent doctoral thesis from the Norwegian University of Science and Technology (NTNU), more than 500 caregivers describe ...
This important work offers a fresh perspective central to merozoite surface biology and potential implications on vaccine design, challenging the dogma that MSPs are indispensable invasion engines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results